Hospital for Special Surgery (HSS) plans to host a two-day international Osteoarthritis Summit in June 2011…

Read The Full Article…Hospital For Special Surgery To Host International Arthritis Summit In 2011 Read more »

A literature review, led by Dr. Joseph Lee, published in the June 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) suggests that a herniated disk is one of the most frequent causes of low back and leg pain in adults, but surgery is not for everyone…

Read The Full Article…Literature Review [...] Read more »

Arthroscopic surgical repair of torn anterior cruciate ligaments (ACL) or meniscal cartilage injuries in the knee does not decrease the chances of developing osteoarthritis, according to a new study published in the online edition and August print issue of the journal Radiology…

Read The Full Article…Surgical Repair Of Knee Injuries Does Not Decrease Risk Of Osteoarthritis Read more »

In draft final guidance published today, (25 June 2010) NICE recommends rituximab, adalimumab, etanercept, infliximab and abatacept, in certain circumstances, as possible treatments for rheumatoid arthritis after treatment with a tumour necrosis factor (TNF) inhibitor has failed…

Read The Full Article…NICE Recommends Treatments For Rheumatoid Arthritis After The Failure Of A TNF Inhibitor Read more »

A recent study determined that bone area predicted the development of medial (inner side) and lateral (outer side) knee cartilage damage and loss of medial cartilage volume. Subchondral bone mineral density (BMD) was associated with medial defect development but not cartilage loss…

Read The Full Article…Subchondral Bone Changes Contribute To Cartilage Damage And Loss Read more »

Cardio-Respiratory Aerobic Conditioning Improves Function; Lessens Joint Pain Researchers from the University of Grenoble Medical School in France determined that cardio-respiratory aerobic exercise is safe for patients with stable rheumatoid arthritis (RA). The team found that RA patients who exercised regularly had improved function, less joint pain, and greater quality of life…

Read The Full Article…Aerobic [...] Read more »

Disease-modifying antirheumatic drugs (DMARDs) should be used early and aggressively at the first sign of rheumatoid arthritis (RA). The results of an 11-year trial, published in BioMed Central’s open access journal Arthritis Research & Therapy, demonstrate that active treatment from the very beginning pays off, even in the long run…

Read The Full Article…A Recommendation For [...] Read more »

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), announced today that it has begun the drug registration process in Panama for its Nyloxin pain reliever…

Read The Full Article…Nutra Pharma Begins Drug Registration Process In Central America For Its Nyloxin Pain Reliever Read more »

“The objective was to evaluate the utility of cryo-preserved human amniotic membrane (HAM) as a support for repairing human articular cartilage injuries, which have a very limited capacity for self-healing”, Francisco J. Blanco, lead author of the study and a researcher at the Institute of Biomedical Research of La Coruna (INIBIC), tells SINC…

Read The Full [...] Read more »

Pfizer Inc. (NYSE: PFE) announced the suspension of the osteoarthritis clinical program for the investigational compound tanezumab following a request by the U.S. Food and Drug Administration (FDA). The worldwide suspension which is effective immediately follows a small number of reports of tanezumab patients experiencing the worsening of osteoarthritis leading to joint replacement…

Read [...] Read more »